» Articles » PMID: 35057109

Electrospraying As a Technique for the Controlled Synthesis of Biocompatible PLGA@AgS and PLGA@AgS@SPION Nanocarriers with Drug Release Capability

Abstract

AgS nanoparticles are near-infrared (NIR) probes providing emission in a specific spectral range (~1200 nm), and superparamagnetic iron oxide nanoparticles (SPION) are colloidal systems able to respond to an external magnetic field. A disadvantage of AgS NPs is the attenuated luminescent properties are reduced in aqueous media and human fluids. Concerning SPION, the main drawback is the generation of undesirable clusters that reduce particle stability. Here, we fabricate biocompatible hybrid nanosystems combining AgS NPs and SPION by the electrospraying technique for drug delivery purposes. These nanostructures are composed of poly(lactic-co-glycolic acid) (PLGA) as the polymeric matrix in connection with both AgS NPs and SPIONs. Initially, we fabricate a hybrid colloidal nanosystem composed of AgS NPs in connection with PLGA (PLGA@AgS) by three different routes, showing good photoluminescent (PL) properties with relatively high average decay times. Then, we incorporate SPIONs, obtaining a PLGA polymeric matrix containing both AgS NPs and SPION (PLGA@AgS@SPION). Interestingly, in this hybrid system, the location of AgS NPs and SPIONs depends on the synthesis route performed during electrospraying. After a detailed characterization, we demonstrate the encapsulation and release capabilities, obtaining the kinetic release using a model chemotherapeutic drug (maslinic acid). Finally, we perform in vitro cytotoxicity assays using drug-loaded hybrid systems against several tumor cell lines.

Citing Articles

Magnetic Nanoparticles with On-Site Azide and Alkyne Functionalized Polymer Coating in a Single Step through a Solvothermal Process.

Mora-Cabello R, Fuentes-Rios D, Gago L, Cabeza L, Moscoso A, Melguizo C Pharmaceutics. 2024; 16(9).

PMID: 39339262 PMC: 11435388. DOI: 10.3390/pharmaceutics16091226.


Nanomedical research and development in Spain: improving the treatment of diseases from the nanoscale.

Fernandez-Gomez P, Perez de la Lastra Aranda C, Tosat-Bitrian C, Bueso de Barrio J, Thompson S, Sot B Front Bioeng Biotechnol. 2023; 11:1191327.

PMID: 37545884 PMC: 10401050. DOI: 10.3389/fbioe.2023.1191327.


Anticancer Nanotherapeutics in Clinical Trials: The Work behind Clinical Translation of Nanomedicine.

Parodi A, Kolesova E, Voronina M, Frolova A, Kostyushev D, Trushina D Int J Mol Sci. 2022; 23(21).

PMID: 36362156 PMC: 9656556. DOI: 10.3390/ijms232113368.


Emerging Bioactive Agent Delivery-Based Regenerative Therapies for Lower Genitourinary Tissues.

Da L, Sun Y, Lin Y, Chen S, Chen G, Zheng B Pharmaceutics. 2022; 14(8).

PMID: 36015344 PMC: 9414065. DOI: 10.3390/pharmaceutics14081718.

References
1.
Zhang S, Geryak R, Geldmeier J, Kim S, Tsukruk V . Synthesis, Assembly, and Applications of Hybrid Nanostructures for Biosensing. Chem Rev. 2017; 117(20):12942-13038. DOI: 10.1021/acs.chemrev.7b00088. View

2.
Reyes-Zurita F, Rufino-Palomares E, Lupianez J, Cascante M . Maslinic acid, a natural triterpene from Olea europaea L., induces apoptosis in HT29 human colon-cancer cells via the mitochondrial apoptotic pathway. Cancer Lett. 2008; 273(1):44-54. DOI: 10.1016/j.canlet.2008.07.033. View

3.
Zhu L, Li M, Liu X, Jin Y . Drug-Loaded PLGA Electrospraying Porous Microspheres for the Local Therapy of Primary Lung Cancer via Pulmonary Delivery. ACS Omega. 2018; 2(5):2273-2279. PMC: 6044788. DOI: 10.1021/acsomega.7b00456. View

4.
Xing L, Xu S, Cui J, Wang L . Solvent Tailored Strategy for Synthesis of Ultrasmall Ag₂S Quantum Dots with Near-Infrared-II Luminescence. J Nanosci Nanotechnol. 2019; 19(8):4549-4555. DOI: 10.1166/jnn.2019.16351. View

5.
Marciello M, Pellico J, Fernandez-Barahona I, Herranz F, Ruiz-Cabello J, Filice M . Recent advances in the preparation and application of multifunctional iron oxide and liposome-based nanosystems for multimodal diagnosis and therapy. Interface Focus. 2016; 6(6):20160055. PMC: 5071816. DOI: 10.1098/rsfs.2016.0055. View